Evaluation of three NT-proBNP assays for heart failure
Three NT-proBNP assay platforms demonstrated high correlation, minimal bias, and high clinical concordance. The results support the clinical interchangeability of these assays at commonly used and guideline-endorsed cutpoints.
Authors
- David Daghfal (ORCID: https://orcid.org/0009-0007-9258-7898)
- Brittany Roemmich
- Christopher W Farnsworth (ORCID: https://orcid.org/0000-0001-7169-3850)
- Christian J. Hunter (ORCID: https://orcid.org/0000-0003-4744-463X)
- Annette B. Wysocki (ORCID: https://orcid.org/0009-0003-3607-0764)
- Sydney Lawless
- Isaiah K Mensah
Institutions
- Washington University in St. Louis (US)
- Abbott Fund (US)
Publication Details
- Journal
- Clinical Biochemistry
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1016/j.clinbiochem.2025.111062
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00